What's New

  • 01 Oct 2018
    Antares Receives FDA Approval of XYOSTED™ (Testosterone Enanthate) Injection for Testosterone Replacement Therapy in Adult Males Read More

  • 16 Aug 2018
    Antares Pharma Announces FDA Approval of Generic Epipen Utilizing Vibex Auto Injector Read More

  • 07 Aug 2018
    Antares Pharma Reports Second Quarter 2018 Operating and Financial Results Read More

ATRS

Quotes delayed at least 15 minutes